Heidelberg Pharma
Latest round
- Series B
Last raised
- Oct 2006
Total raised
- $20M
Investors
- 1
About Heidelberg Pharma
Based in Ladenburg Deutschland, Germany, and founded in 1997, Heidelberg Pharma AG formerly known as Wilex Biotechnology GmbH operates as a biotechnology that develops the toxin Amanitin into cancer therapies using its proprietary Antibody Targeted Amanitin Conjugate. The company develops Antibody Drug Conjugates (ADCs) for the treatment of oncological diseases. The technology used by the firm uses Amanitin. The firm has various products which are in the research phase named HDP-104, and HDP- XX having indication gastrointestinal and solid and hematological tumors respectively.
Who invested in Heidelberg Pharma
1 investor across 1 round
See all investors in Heidelberg Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Oct 2, 2006
Amount
$20M
Investors
Questions about Heidelberg Pharma
Who invested in Heidelberg Pharma?
Heidelberg Pharma has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Heidelberg Pharma raised?
Heidelberg Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Heidelberg Pharma last raise money?
Heidelberg Pharma's most recent round on record is a Series B, in Oct 2006.
What does Heidelberg Pharma do?
Based in Ladenburg Deutschland, Germany, and founded in 1997, Heidelberg Pharma AG formerly known as Wilex Biotechnology GmbH operates as a biotechnology that develops the toxin Amanitin into cancer therapies using its proprietary Antibody Targeted Amanitin Conjugate.
Where is Heidelberg Pharma headquartered?
Heidelberg Pharma is headquartered in Germany.
Which VCs invest in companies like Heidelberg Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Heidelberg Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Heidelberg Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.